30.06.2014 Views

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

Small Animal Clinical Pharmacology - CYF MEDICAL DISTRIBUTION

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

CHAPTER 5 ANESTHETIC AGENTS<br />

Table 5.3 Uses of local anesthetics<br />

Drug Topical Infiltration Peripheral nerve block Intravenous regional analgesia Epidural<br />

Procaine + +<br />

Proxymetacaine +<br />

Lidocaine + + + + +<br />

Prilocaine +<br />

Mepivacaine + + +<br />

Bupivacaine + + +<br />

Ropivacaine + + +<br />

doses may be lower in cats and doses should not exceed<br />

4 mg/kg lidocaine, 2.5 mg/kg mepivacaine or 1.5 mg/kg<br />

bupivacaine. Toxicity is additive and if combinations of<br />

local anesthetics are used the dose of individual drugs<br />

should be reduced accordingly.<br />

A<br />

Aromatic group<br />

O<br />

C<br />

O<br />

Amine side-chain<br />

Infiltrative block<br />

● 0.5–2% lidocaine or 0.125–0.5% bupivacaine or<br />

1.0–2.0% mepivacaine<br />

● Solutions containing adrenaline (epinephrine)<br />

should not be used to desensitize extremities<br />

● Dilution with 0.9% sodium chloride is<br />

recommended to minimize the overall dose<br />

Peripheral nerve blocks<br />

● 0.5–2.0% lidocaine or 0.125–0.5% bupivacaine or<br />

1.0–2.0% mepivacaine<br />

● 0.25–2.0 mL per site<br />

Intra-articular analgesia<br />

● Up to 1 mL/4.5 kg of 2% lidocaine or 0.5%<br />

bupivacaine<br />

● Mepivacaine may cause less tissue irritation and<br />

has also been recommended for intra-articular use<br />

Interpleural blockade<br />

● 1–2 mg/kg 0.25% bupivacaine in dogs (0.5 mg/kg<br />

in cats)<br />

Intravenous regional analgesia in dogs<br />

(Bier block)<br />

● 2.5–5 mg/kg lidocaine without adrenaline<br />

(epinephrine) is injected into a superficial vein<br />

distal to a tourniquet<br />

● The tourniquet must be removed within 60–90 min<br />

● Bupivacaine is more cardiotoxic than lidocaine and<br />

should not be used<br />

Lumbosacral epidural<br />

● In dogs 1 mL/4.5 kg of 2% lidocaine or 0.5%<br />

bupivacaine<br />

● In cats 1 mL/4.5 kg of 2% lidocaine or 1 mL/7 kg<br />

of 0.5% bupivacaine<br />

B<br />

Aromatic group<br />

NH<br />

● The total volume of drug injected epidurally should<br />

not exceed 6 mL in dogs or 1.5 mL in cats<br />

Pharmacokinetics<br />

O<br />

C<br />

Amine side-chain<br />

Fig. 5.5 Basic chemical structure of (A) an ester-linked<br />

and (B) an amide-linked local anesthetic.<br />

Most local anesthetics share a common chemical structure<br />

comprising a lipophilic aromatic ring linked to a<br />

hydrophilic amine side chain by an ester or amide bond<br />

(see Fig. 5.5). The amphiphilic nature of the molecule<br />

is important in conferring both lipid- and water-soluble<br />

characteristics. The linkage also has an impact on the<br />

biotransformation of the drug and local anesthetics can<br />

be classified as being ester or amide linked.<br />

Most local anesthetics are weak bases and are largely<br />

ionized at physiological pH. Only unionized drug is<br />

sufficiently lipid soluble to diffuse through the axon<br />

membrane to reach the binding site within the ion<br />

channel. Therefore a drug that is less ionized at physiological<br />

pH will have a faster onset than a highly ionized<br />

drug (see Table 5.4). This explains the slow onset time<br />

of bupivacaine (20–30 min) compared to lidocaine (10–<br />

15 min). Once the drug gains access to the channel it is<br />

the ionized form that binds most avidly to the receptor.<br />

The degree of ionization can be influenced by the pH of<br />

the tissues. Inflammation tends to lower pH and this can<br />

increase ionization sufficiently to interfere with drug<br />

activity.<br />

The lipid solubility of a local anesthetic is correlated<br />

to potency: the more lipid soluble the agent, the greater<br />

the potency. Protein binding is variable (see Table 5.4).<br />

110

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!